TGFB1 and Hepatic fibrosis: BBR also prevented the expression of transforming growth factor (TGF-β1), and α-smooth muscle actin (α-SMA), which are markers of activated HSC transitioning from quiescence to myofibroblast (MFB)-like cells, and thereby reversed liver fibrosis [41].